The commercially available steroid dehydroepiandrosterone 3-acetate (DHEA) was converted into steroidal D-ringfused pyrrolidines that combine two privileged structures: a steroid and a (2-arylethyl)amine. The three-step transformations proceeded through conversion of the C-17 ketone into an enol
Introduction
Steroids fused through the D-ring to various types of heterocycles, including pyridines, [1] pyrimidines, [2] pyridazines, [3] thiazoles, [4] imidazoles, [1b] pyrazoles, [5] indoles, [6] and polyheterocyles, [4, 7] have become part of a growing research field. Members of this class of compounds, which are based on the combination of two medicinally relevant privileged core structures into a single molecule, show diverse biological activities. Interestingly, in several cases, these activities are higher than those of the corresponding steroidal reference drugs. [8] The high therapeutic potential of these steroidal alkaloids against cancer and other diseases has recently been reviewed. [9] The compounds solanidine (1a) and solanine (1b; Figure 1) , [10] which contain a pyrrolidine ring fused to the steroid skeleton, are primary examples of this class of compounds. Solanine in particular has attracted much attention because of its antitumor activity. [11] As part of our research into the preparation of new heterocycle-fused steroids with possible biological activity, in this paper we present new compounds in which the following two privileged structures are combined: (1) (acetyl-protected) dehydroepiandrosterone (DHEA; 2), an endogeneous steroid hormone; and (2) a (2-arylethyl)amine moiety (3) contained within a pyrrolidine framework, another common feature in biologically active natural products and pharmaceutical agents (Scheme 1). [12] It is important to emphasize the biological relevance of the (2-arylethyl)amine moiety, which is encountered in numerous compounds that act on the central nervous system. Scheme 1. Combination of (acetyl-protected) DHEA (2) and (2-arylethyl)amine (3) in a pyrrolidine ring.
Furthermore, this privileged structure is present in neurotransmitters such as dopamine, epinephrine, norepinephrine, and serotonin. [13] We also present model compounds that lack the steroid framework, but helped with the elucidation of the stereochemical outcome of the reactions, and that could shed light on the mechanism of action in a drug-discovery program.
A sequence suitable for this synthesis was recognized in the cascade [4+2]/[3+2] cycloadditions studied by Denmark and others. [14] In this approach, a nitroalkene (e.g., nitrostyrene) reacts with an enol ether to form a six-membered cyclic azinate (formerly known as nitronate), which then reacts further with a selected alkene in a 1,3-dipolar cycloaddition reaction to produce an azonite. From there, (arylethyl)amines are accessible by reduction of the azonite functionality. A retrosynthesis of the target compounds is presented in Scheme 2. Starting from the anticipated pyrrolidine derivatives 17-24, the pyrrolidine rings could be derived from compounds 6-16 by reduction of the azonites and subsequent intramolecular reductive amination. A multicomponent cycloaddition should take place to generate these compounds from enol ethers 4 and 5, which in turn could be derived from cyclopentanone and acetyl-protected DHEA (2; Scheme 2). It was discovered by Uitenbogaard et al. that the [4+2]/[3+2] cycloaddition is greatly accelerated by the use of high pressure.
[15] High pressure is also important to overcome the low reactivity of the C-17 position of steroids due to the presence of the C-ring and the methyl group (C-18) at the C-D ring junction. [16] Thus, we were prompted by the synthetic challenge to synthesize a pyrrolidine E-ring fused to DHEA through a high-pressure-promoted cycloaddition reaction. 
Results and Discussion
The synthesis of the model compounds began with the known formation of enol ether 4. [17] The high-pressure-promoted multicomponent cycloadditions were carried out with enol ether 4, nitroalkene 25, and dipolarophiles with different functional groups (26) (27) (28) (29) (30) . [18, 19] The [4+2] and [3+2] cycloaddition reactions took place with complete regioselectivity [20] to give azonites 6-10 as mixtures of only two diastereoisomers (a and b), via azinate intermediates 31 (Scheme 3, Table 1 ). In most cases, only the major isomer (a) could be isolated in pure form. The cycloaddition reactions of the electron-deficient dipolarophiles (Table 1 , Entries 2 and 4) gave higher product yields than the reactions of electron-rich alkenes (Table 1, Entries 1, 3, and 5) . These results were expected, based on the known HOMO azinate -LUMO dipolarophile interaction. [21] No product from the competing cycloaddition of azinate 31 with enol ether 4 was observed, probably because of the higher steric hindrance of this trisubstituted alkene compared with the monosubstituted dipolarophiles, and the higher energy of its LUMO. [a] Calculated from the isolated products after purification. It was not possible to determine the ratio from the crude mixtures. [b] Combined yield.
Stereochemical elucidation was carried out based on the single-crystal X-ray diffraction analysis of compound 7a and extensive NMR spectroscopic analysis of 7a and 7b (Figure 2 ). [23] These two compounds show the same coupling pattern and the same coupling constant values for 3a-H (q, J = 8.1-8.2 Hz), indicating a similar dihedral angle and therefore the same configuration at C-3a. The stereoisomerism of azinate 31 could be explained by a stereoselective hetero-Diels-Alder cycloaddition of nitroalkene 25 and the heterodiene with the methoxy group approaching in an endo fashion (Scheme 4). [24] Scheme 4. Hetero-Diels-Alder cycloaddition for the formation of azinate 31.
Then, a regio-and stereoselective 1,3-dipolar cycloaddition of azinates 31 and dipolarophiles 26-30 yielded azonites 6-10. In all cases, the major products were formed through an exo approach of the dipolarophile exclusively on the Re face of the azinates, probably because of the presence of the phenyl group (Scheme 5). The final pyrrolidines were synthesized by reduction of the corresponding azonites. Azonites 6a-10a were hydrogenated with Raney nickel in methanol at room temperature to give pyrrolidines 17a-20a in fair to excellent yields (Scheme 6, Table 2 ). [25] Azonite 7a formed a mixture of pyrrolidine 18a and pyrrolizidinone 34a (Table 2, Entry 2) [26] by cyclization of the pyrrolidine with the ester. [27] Pyrrolidines 17a-20a were formed by the stereoselective reduction of imines 33, [28] which in turn were presumably formed by intramolecular condensation of Scheme 6 . Reduction of azonites 6a-10a to form pyrrolidines 17a-20a and pyrrolizidinone 34a. 
The product was isolated as the triacetyl derivative.
The synthesis of the corresponding steroid derivatives took place similarly to the synthesis of the model compounds. Treatment of acetyl-protected DHEA (2) with trimethyl orthoformate in methanol with H 2 SO 4 as catalyst gave the corresponding dimethyl acetal, and subsequent demethanolization by distillation gave enol ether 5 in 63 % yield. [29] The high-pressure-promoted multicomponent cycloadditions were carried out with enol ether 5, nitroalkene 25, and the same dipolarophiles 26-30. [18, 19] We also included one example using 1-nitro-4-phenylbuta-1,3-diene (35) to achieve a pyrrolidine bearing a (4-phenylbutyl)amine moiety instead of a (2-arylethyl)amine for biological comparison. These cycloaddition reactions took place again with complete regioselectivity and gave azonites 11-16 as mixtures of two or three diastereoisomers (Scheme 7, Table 3 ). Clearly, the steroid and cyclopentane rings influence the 1,3-cycloaddition reactions differently. Again in most cases, only the major isomer (a) could be isolated in pure form. The cycloadditions of the electron-deficient dipolarophiles (Table 3 , Entries 2, 4, and 6) resulted again in higher yields of the products. C NMR spectra with the corresponding spectra of azinates 6-10. The hetero-Diels-Alder cycloaddition of enol ether 5 and heterodienes 25 and 35 took place through reaction on the bottom face of enol ether 5 as a result of the presence of the -methyl group at C-13. [30] The formation of isomers c of the steroid derivatives could be due to the presence of the -methyl group at C-13. This methyl group might force the methoxy group into a different conformation, and at the same time this may change the conformation of the dihydrooxazine ring of azinates 31, placing the R 2 group (Ph or PhCH=CH) away from the top face.
Finally, the target steroid-derived pyrrolidines were synthesized by reduction of azonites 11a-16a under the same conditions as before (Raney-Ni, MeOH, 23°C) to give pyrrolidines 21a-24a in fair to good yields (Scheme 8, Table 4 ). [25] The reduction of azonites 14a and 15a did not provide the corresponding pyrrolidines, but gave mixtures of unidentified compounds. The stereochemistry at C-17 was determined by comparison of the coupling constants between 16-H and 17-H of compounds 17a, 18a, and 20a (J = 7.0-8.2 Hz). [31] Scheme 8. Reduction of azonites 11a-16a to form pyrrolidines 21a-24a. [a] R 2 is PhCH 2 CH 2 after the reduction.
Conclusions
The realm of azasteroids is continuously expanding. New pyrrolidines fused to (acetyl-protected) dehydroepiandrosterone on the D-ring can be synthesized in three steps, of which a highpressure-promoted multicomponent cycloaddition reaction is the key step. The resulting model and steroidal compounds presented in this publication will be tested and their properties evaluated to demonstrate the influence of the steroid part of the molecules. 
